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Abstract 
Objective To explore early impacts of China's health reforms in 2009 on mortality. Methods Annual 
mortality counts were obtained from 161 counties across all 31 provinces of mainland China between 
2006 and 2012. We examined time-series of health service amenable mortality counts, including separate 
analyses for deaths from stroke and ischaemic heart diseases (IHD). Non-amenable mortality counts, 
including separate models for oesophageal and pancreatic cancers, were also analysed as part of a 
negative-outcome strategy to provide stronger foundations for falsification. Deaths due to amenable 
causes were hypothesised to decrease, whereas non-amenable causes of mortality would remain 
uninfluenced. All analyses were conducted using multilevel negative binomial regression. Results 
Geographical variation was observed for each mortality indicator, especially for IHD, oesophageal and 
pancreatic cancers. Negative covariances in all models indicated slight degrees of convergence in these 
geographic variations over time (but not significantly for deaths from oesophageal and pancreatic 
cancers). Linear and square functions of time indicated a curvilinear inverted parabolic trend between 
2006 and 2012 for stroke and IHD mortality. Reduction in health-service amenable mortality over time 
was observed, but also for health service non-amenable mortality, including deaths from oesophageal 
cancer. Pancreatic cancer was found to increase across the study period. In counties where residents had 
more years of education, mortality from stroke was lower and reducing faster over time. A similar 
spatiotemporal patterning was observed for deaths from oesophageal cancer, and health service 
amenable and non-amenable causes. Counties with higher mean education years had higher mortality 
from IHD and pancreatic cancer, but also larger reductions in mortality were evident in areas with greater 
years of education. Conclusions Although there was no clear evidence of an early impact of China's health 
reform on mortality, this does not rule out potentially important contributions to reducing the burden of 
disease in the longer term. 
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Objective: To explore early impacts of China’s health
reforms in 2009 on mortality.
Methods: Annual mortality counts were obtained from
161 counties across all 31 provinces of mainland
China between 2006 and 2012. We examined time-
series of health service amenable mortality counts,
including separate analyses for deaths from stroke and
ischaemic heart diseases (IHD). Non-amenable
mortality counts, including separate models for
oesophageal and pancreatic cancers, were also
analysed as part of a negative-outcome strategy to
provide stronger foundations for falsification. Deaths
due to amenable causes were hypothesised to
decrease, whereas non-amenable causes of mortality
would remain uninfluenced. All analyses were
conducted using multilevel negative binomial
regression.
Results: Geographical variation was observed for each
mortality indicator, especially for IHD, oesophageal and
pancreatic cancers. Negative covariances in all models
indicated slight degrees of convergence in these
geographic variations over time (but not significantly
for deaths from oesophageal and pancreatic cancers).
Linear and square functions of time indicated a
curvilinear inverted parabolic trend between 2006 and
2012 for stroke and IHD mortality. Reduction in health-
service amenable mortality over time was observed,
but also for health service non-amenable mortality,
including deaths from oesophageal cancer. Pancreatic
cancer was found to increase across the study period.
In counties where residents had more years of
education, mortality from stroke was lower and
reducing faster over time. A similar spatiotemporal
patterning was observed for deaths from oesophageal
cancer, and health service amenable and non-amenable
causes. Counties with higher mean education years
had higher mortality from IHD and pancreatic cancer,
but also larger reductions in mortality were evident in
areas with greater years of education.
Conclusions: Although there was no clear evidence of
an early impact of China’s health reform on mortality,
this does not rule out potentially important
contributions to reducing the burden of disease in the
longer term.
INTRODUCTION
Commentators suggest that a universal
health insurance which provides access to
good quality health services not only helps
enhance health and prevents disease,1 but
also serves to reduce socioeconomic
inequity2 and strengthens the workforce.3
The pursuit for universal health coverage has
been reflected in developments over the past
10–15 years in China, including the land-
mark reforms of 2009. China’s government
began to re-establish rural health insurance
from 2002 in which all rural Chinese resi-
dents were eligible to enrol.4 Attention then
focused on cities with the launch of the
urban resident basic health insurance in
2007.5 This was followed by China’s land-
mark reforms in 2009, which led to the rapid
expansion of health insurance to over 90%
of the population by the end of 2010.6 Five
years on, we investigated whether the
Chinese government’s investment of CN¥850
billion (US$125 billion) had early impacts
on public health.
While universal health coverage is
regarded as central to social and economic
policy3 and a vital component for achieving
health equity,7 the scientific evidence of
Strengths and limitations of this study
▪ Annual mortality time-series data from 161 loca-
tions across all 31 provinces of China.
▪ Multilevel random intercept-slope models to
investigate spatiotemporal variation.
▪ Recognised classification of health service
‘amenable’ mortality.
▪ Use of ‘negative outcome’ technique with health
service ‘non-amenable’ mortality.
▪ Data on geographic variation in health policy
implementation is needed.
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health its impact is mixed.8 Population-wide investiga-
tions of the impact of universal health insurance are
rare,9 with most focusing either on young children10–13
or the elderly.14 15 Previous work on the implementation
of universal health coverage from 1995 onwards in
Taiwan, for example, has reported a rise in health
service utilisation among the newly insured16 and a mar-
ginally steeper rise in life expectancy within communi-
ties that had higher mortality rates before 1995.17 Yet
both favourable and null findings have been reported
on possible improvements in health status and reduc-
tions in mortality.18 19 The potential health impact of
implementing universal health coverage is uncertain in
a society as socially and geographically diverse as
China.20 Furthermore, given the proliferation of particu-
lar diseases and causes of death amenable to healthcare
intervention in particular areas of China, it is unlikely
that any early impacts on health have been uniform
across this vast country.
Accordingly, the aim of our study was to use a nation-
ally representative time series data (2006–2012) across
mainland China spanning the period prior and subse-
quent to the 2009 reform to explore for early impacts of
the expansion of universal coverage on public health.
METHODS
Assessments of possible change in disease incidence and
associated risk factors at this present time are unlikely to
yield substantial findings given that near-universal health
coverage was only recently achieved in China and the
lag-times on these outcomes make them more suitable
to long-term follow-up. However, the influence of the
exogenous expansion in health coverage may be observ-
able within the short-term by tracking ‘health service
amenable mortality’21 before and subsequent to 2009.
The hypothesis is that the near-universal health coverage
will have helped to raise standards of living, enhance
health promotion and promoted greater equity of access
to life-saving health services. The impact would then
manifest in downward trends in mortality attributable to
preventable causes, such as stroke and ischaemic heart
disease (IHD).
To enhance this pre–post time-series analysis we lever-
aged a negative outcome study design22 wherein causes of
death that could not have been affected by the health
reforms were also analysed. This analysis of so-called
‘negative outcomes’ provides additional foundations for
falsifiability of the main hypothesis that expansion of
health service coverage had a favourable impact on health
service amenable mortality. For this purpose, we selected
oesophageal and pancreatic cancers specifically due to
their short survival times,23 24 as well as the broader group
of mortality causes that are not classified as ‘amenable’.
Access to annual mortality counts for 161 ‘disease sur-
veillance points’ (DSP) was provided by the Chinese
Center for Disease Control and Prevention (China CDC).
The DSP is nationally representative and covers a sample
population of approximately 73 million people, including
urban and rural counties in all 31 provinces, municipal-
ities and autonomous regions within China. Amenable
mortality (table 1) and other mortality counts were strati-
fied by year, gender and age group (50–59 years, 60–
69 years, 70–79 years, 80+ years) at the DSP level for years
2006–2012 inclusive. Population counts from the 2010
census were used to ascertain denominators.
Table 1 Amenable mortality definition
No Name Age ICD10
1 Intestinal infections 0–14 A00-A09
2 Tuberculosis 0–74 A15-A19,
B90




4 Whooping cough 0–14 A37
5 Septicaemia 0–74 A40-A41
6 Measles 1–14 B05
7 Malignant neoplasm of colon
and rectum
0–74 C18-C21
8 Malignant neoplasm of skin 0–74 C44
9 Malignant neoplasm of breast 0–74 C50
10 Malignant neoplasm of cervix
uteri
0–74 C53
11 Malignant neoplasm of cervix
uteri and body of the uterus
0–44 C54, C55
12 Malignant neoplasm of testis 0–74 C62
13 Hodgkin’s disease 0–74 C81
14 Leukaemia 0–44 C91-C95
15 Diseases of the thyroid 0–74 E00-E07
16 Diabetes mellitus 0–49 E10-E14
17 Epilepsy 0–74 G40-G41
18 Chronic rheumatic heart
disease
0–74 I05-I09
19 Hypertensive disease 0–74 I10-I13,
I15
20 Ischaemic heart disease 0–74 I20-I25
21 Cerebrovascular disease 0–74 I60-I69





23 Influenza 0–74 J10-J11
24 Pneumonia 0–74 J12-J18
25 Peptic ulcer 0–74 K25-K27
26 Appendicitis 0–74 K35-K38
27 Abdominal hernia 0–74 K40-K46
28 Cholelithiasis and cholecystitis 0–74 K80-K81
29 Nephritis and nephrosis 0–74 N00-N07,
N17-N19,
N25-N27
30 Benign prostatic hyperplasia 0–74 N40








34 Misadventures to patients
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Socioeconomic circumstances were measured using the
mean years of education among residents within each
DSP, also extracted from the 2010 census.
Descriptive analysis was conducted by calculating the
mean annual mortality count for each cause of death for
2006–2012 inclusive. Statistical analysis was conducted via
multilevel negative binomial regression with random coef-
ficients to investigate potential spatiotemporal variation in
each mortality count.25 An assumption of a standard
random intercept multilevel model is that the relationship
between and outcome and exposure is the same regard-
less of the higher level unit, such as a geographic area. By
fitting a random coefficient between DSPs and time in
our models, we allowed the relationship between mortality
and time to vary between DSPs, henceforth making poten-
tial geographic deviations in mortality trends (ie, spatio-
temporal variation) more observable.
Initial models were fitted with gender, age group and
year as fixed effects. The year variable was fitted as in
the form of linear and square terms to explore for
potential curvilinear trends. This was to help account for
the hierarchical data structure, wherein each DSP-level
mortality count was stratified by gender, age group and
year. Henceforth, level 1 within the model was the
DSP-level mortality count for every combination of
gender, age group and year, nested within DSPs at level
2. Linear and square functions of year were fitted into
the model to assess for deviation in the mortality trends
through time. The degree of potential spatiotemporal
variation was assessed by observing the covariance of the
random slopes. DSP-level variances were re-expressed as
median rate ratios (MRR). The DSP-level mean years of
education was then added to each model along with an
interaction with year to explore whether there was
change in the level of socioeconomic inequity over the
time period. All fixed effect parameters were exponen-
tiated to rate ratios (RR) and 95% CIs. All analyses were
conducted in MLwIN V.2.30 using penalised quasi-
likelihood with second order Taylor series expansion to
correct for downwardly biased variances.
RESULTS
Mean health service amenable mortality was observed at
151.5/100 000 in 2006, rising to 164.1/100 000 by 2008,
but then decreasing from 2009 onwards to 150.7/
100 000 by 2012 (table 2). Stroke mortality appeared to
follow a similar inverted parabolic trend, whereas IHD
mortality increased across the study period.
Non-amenable mortality increased from 453.7/100 000
in 2006 to 495.0/100 000 in 2008, falling to 487.2/
100 000 by 2012. Mortality from pancreatic cancer
increased across the study period, but deaths from
oesophageal cancer decreased.
Substantial geographical variation was observed for
mortality counts from stroke (MRR 1.76), IHD (1.99;
table 3), oesophageal cancer (2.76) and pancreatic
cancer (1.95; table 4). The spatial patterning of health
service amenable (1.49) and non-amenable (1.28) mor-
tality counts was less varied by comparison (table 5). In
models unadjusted for socioeconomic circumstances
(model 1s, tables 3–5), stroke and IHD mortality
increased but then curved downward over time period
(table 3). Deaths from oesophageal cancer also reduced
but those from pancreatic cancer increased (table 4).
Both health service amenable and non-amenable causes
of death appeared to decline across the study period
(table 5). The covariances indicated a slight narrowing
of the geographic variation of these mortality counts
through the study period.
Adjusting for socioeconomic circumstances did not
markedly change these results. Higher mean years of
education in a DSP was associated with lower mortality
from stroke, oesophageal, health service amenable and
non-amenable mortality, but also higher IHD and pan-
creatic cancer mortality. Interaction terms indicated
some degree of change in the socioeconomic patterning
of each mortality outcome over time, with potential nar-
rowing of the gradient for IHD and pancreatic cancer,
but widening for other causes of death due to larger
reductions in areas with greater years of education.
DISCUSSION
Unprecedented change in built, physical and socio-
economic environments associated with rapid urbanisa-
tion have manifested unevenly across China, presenting
major challenges in disease prevention and detec-
tion.26 27 The expansion of health coverage in China as
a result of the 2009 reforms has been interpreted an
important step towards ensuring access to healthcare
and protecting health in the long term. In the short
Table 2 Mortality count for each cause of death per 100 000 people, by year
Year Amenable
Ischaemic





2006 151.5 58.5 120.0 453.7 3.2 12.3
2007 154.6 70.3 127.7 468.6 3.7 13.0
2008 164.1 78.3 144.8 495.0 3.7 12.7
2009 155.3 81.7 141.9 473.2 3.7 11.9
2010 151.6 85.6 142.6 471.1 3.7 11.1
2011 152.6 89.8 141.7 469.9 4.2 10.8
2012 150.7 96.4 141.6 478.2 4.1 10.7
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term, has the expansion of health insurance in China
had appreciable and early benefits or not? Building on
recent work,28 29 our study found mixed evidence for
early impacts on mortality. Evidence in support of an
early benefit was from the declines in mortality from
health service amenable causes. The curvilinear trend of
stroke and IHD mortality (rising initially then falling), is
not at odds with wider literature on the nutrition transi-
tion in China30–32 but is insufficient to discount an early
benefit of the health reform on its own. The concurrent
upward trajectory in deaths from pancreatic cancer,
which would not be expected to be influenced by the
expansion of health coverage, lends support. However,
declines in oesophageal cancer mortality and non-
amenable causes more generally suggests that reductions
in amenable mortality cannot be solely attributed to the
2009 health reform.
The provision of universal health insurance remains a
fundamental determinant of health33 and the equivocal
findings from our study do not rule out the likely social
and economic benefits experienced in many communi-
ties across mainland China. A full appreciation of the
costs and benefits will only become clearer over time
and with epidemiological studies on a range of health
outcomes, including time-series analyses of mortality
counts. The classification of mortality into causes of
death that are recognised to be health service amenable
and non-amenable21 has been previously used to assess
the impact of a health insurance coverage expansion in
Taiwan.18 Our findings are similar in that mortality from
amenable and non-amenable causes decreased during
the study period. This comparison afforded a negative
outcome study design,22 a method which provides stron-
ger grounds for assessing the potential impacts of the
health reform intervention. It should be noted, however,
that the negative outcome approach does not necessarily
provide strong evidence for or against causation. The
degree of health coverage policy implementation and
benefits likely varied across China but we do not have
access to data with which to measure that spatiotemporal
diffusion and variation in exposure. It is plausible, for
example, that while the less socioeconomically well-off
areas and rural communities in particular could have
potentially benefitted most from the health reform,
these communities may also have been less likely to
receive full implementation of the policy within the
Table 3 Spatiotemporal trajectories and socioeconomic inequities in mortality from stroke and ischaemic heart disease
Stroke mortality Ischaemic heart disease mortality
Model 1 Model 2 Model 1 Model 2
Fixed part Rate Ratio (95% CI)
Year 1.08 (1.04 to 1.13) 1.09 (1.05 to 1.13) 1.10 (1.07 to 1.12) 1.10 (1.07 to 1.13)
Year2 0.99 (0.98 to 0.99) 0.99 (0.98 to 0.99) 0.99 (0.99 to 0.99) 0.99 (0.99 to 0.99)
Gender (ref: male)
Female 0.55 (0.54 to 0.57) 0.55 (0.54 to 0.57) 0.45 (0.43 to 0.46) 0.45 (0.43 to 0.46)
Age group (ref: 50–59 years)
60–69 2.92 (2.84 to 2.99) 2.92 (2.84 to 2.99) 2.58 (2.51 to 2.65) 2.58 (2.51 to 2.65)
70–79 9.77 (9.52 to 10.02) 9.77 (9.52 to 10.02) 8.28 (8.06 to 8.51) 8.28 (8.06 to 8.51)
80+ 25.53 (24.89 to 26.19) 25.53 (24.89 to 26.19) 28.65 (27.87 to 29.44) 28.65 (27.87 to 29.44)
Gender×age group (years)
Female×60–69 1.10 (1.06 to 1.15) 1.10 (1.06 to 1.15) 1.37 (1.32 to 1.43) 1.37 (1.32 to 1.43)
Female×70–79 1.25 (1.21 to 1.30) 1.25 (1.21 to 1.30) 1.77 (1.70 to 1.84) 1.77 (1.70 to 1.84)
Female×80+ 1.47 (1.41 to 1.52) 1.47 (1.41 to 1.52) 2.07 (1.98 to 2.15) 2.07 (1.98 to 2.15)
Mean years of
education
0.96 (0.90 to 1.02) 1.16 (1.08 to 1.25)
Year×Mean years of
education
0.94 (0.91 to 0.96) 0.97 (0.95 to 0.98)
Year2×Mean years of
education





0.350 (0.041) [1.76] 0.347 (0.041) [1.75] 0.521 (0.060) [1.99] 0.485 (0.056) [1.94]
Covariance (SE) −0.094 (0.015) −0.101 (0.015) −0.043 (0.010) −0.036 (0.010)




0.010 (0.002) [1.10] 0.011 (0.002) [1.11] 0.004 (0.001) [1.06] 0.003 (0.001) [1.05]
Covariance (SE) −0.007 (0.001) −0.006 (0.001) −0.002 (<0.001) −0.002 (<0.001)
Slope variance (SE) 0.001 (<0.001) 0.001 (<0.001) <0.001 (<0.001) <0.001 (<0.001)
DSP, disease surveillance point; MRR, median rate ratio.
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study period. Were these data to become available to
empirically test, it would be possible to compare trends
in mortality over time in ‘treated’ compared with
‘untreated’ communities within a regression discontinu-
ity framework—an important and under-used study
design for evaluations of the causal impact of large-scale
policies on health.34 35
Previous research conducted on China’s health
reforms provide important context for the findings. A
large repeated cross-sectional study conducted in 2003,
2008 and 2011 assessed trends in access to healthcare
coverage, healthcare activities and financial protection.36
That study reported an increase in healthcare coverage
from 29.7% in 2003 to 95.7% by 2011, indicating a dra-
matic narrowing of inequity of access across regions and
between the poorest and wealthiest. However, this was
accompanied by a notable increase in hospital admis-
sions.37 In 2011, 12.9% of households had health
expenses described as ‘catastrophic’, with rural residents
described as being particularly vulnerable. Another
study, focusing on Shaanxi Province in the west of
China, reported decreasing medicine prices but also
reductions in the availability of the lowest-priced generic
medicines in the public and private sectors between
2010 and 2012.38 This underlines our hypothesis that
while healthcare insurance has achieved virtually univer-
sal coverage in China, there are other related factors
such as the availability of medicines and substantial
health expenses that are likely to vary geographically
and, henceforth, shape spatial inequities in health
outcomes. Further research with large sources of rou-
tinely collected administrative data, as well as bespoke
surveys and qualitative research, are clearly required in
order to fully understand the impact of health reforms
in China.
Further strengths of our study include the wide geo-
graphical scope of the data spanning all 31 provinces
and the analyses of disease-specific causes of mortality
for comparison purposes. The latter was demonstrably
important given the different levels of geographic vari-
ation and temporal trajectories in mortality. Although
deaths from causes that are and are not amenable to
health service intervention are typically grouped separ-
ately, an appreciation of heterogeneity within these
groups is similarly crucial. It is nonetheless vital to note
that DSPs can be very large and within-DSP spatial het-
erogeneity is unobservable with the data available and,
therefore, masks changes in mortality trends at a more
local scale and inequities between different population
groups, such as urban migrants who do not have per-
manent residency status within China’s megacities.39
It is important to acknowledge that the routine surveil-
lance of mortality counts across a country as vast as
China is not trivial. One key challenge is under-
reporting of mortality counts. Previous research40 using
the DSP mortality data analysed in this study found sig-
nificantly higher under-reporting of mortality in rural
compared with urban areas.41 Explanations for this geo-
graphic variation in under-reporting are numerous and
could potentially include less experienced medical and
Table 4 Spatiotemporal trajectories and socioeconomic inequities in mortality from oesophageal and pancreatic cancers
Oesophageal cancer mortality Pancreatic cancer mortality
Model 1 Model 2 Model 1 Model 2
Fixed part Rate ratio (95% CI)
Year 0.98 (0.95 to 1.00) 0.96 (0.93 to 0.99) 1.04 (1.01 to 1.08) 1.06 (1.02 to 1.10)
Year2 1.00 (0.99 to 1.00) 1.00 (0.99 to 1.00) 1.00 (0.99 to 1.00) 0.99 (0.99 to 1.00)
Gender (ref: male)
Female 0.20 (0.19 to 0.21) 0.23 (0.21 to 0.24) 0.59 (0.55 to 0.64) 0.59 (0.55 to 0.64)
Age group (ref: 50–59 years)
60–69 2.38 (2.28 to 2.49) 2.44 (2.31 to 2.56) 2.26 (2.12 to 2.42) 2.27 (2.13 to 2.41)
70–79 4.67 (4.47 to 4.87) 4.84 (4.60 to 5.09) 4.59 (4.30 to 4.89) 4.56 (4.29 to 4.86)
80+ 6.85 (6.52 to 7.19) 7.10 (6.72 to 7.50) 6.01 (5.55 to 6.50) 5.91 (5.48 to 6.36)
Gender×age group (years)
Female×60–69 1.42 (1.31 to 1.54) 1.39 (1.28 to 1.52) 1.14 (1.02 to 1.26) 1.13 (1.02 to 1.25)
Female×70–79 1.81 (1.67 to 1.95) 1.72 (1.58 to 1.88) 1.27 (1.15 to 1.41) 1.26 (1.14 to 1.39)
Female×80+ 2.06 (1.89 to 2.24) 1.88 (1.71 to 2.06) 1.26 (1.12 to 1.42) 1.26 (1.12 to 1.40)
Mean years of education 0.87 (0.77 to 0.98) 1.34 (1.25 to 1.44)
Year×Mean years of education 0.97 (0.95 to 0.99) 0.98 (0.96 to 1.00)
Year2×Mean years of
education





1.131 (0.133) [2.76] 1.189 (0.139) [2.83] 0.488 (0.066) [1.95] 0.343 (0.049) [1.75]
Covariance (SE) −0.024 (0.017) −0.022 (0.016) −0.027 (0.015) −0.007 (0.012)
Slope variance (SE) 0.008 (0.003) 0.003 (0.004) 0.003 (0.005) 0.002 (0.005)
DSP, disease surveillance point; MRR, median rate ratio.
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administrative staff in rural areas, as well as lower levels
of willingness among some bereaved families in rural
areas to report deaths.42 43 A study has been published
comparing compared capture-mark-recapture techni-
ques using a household survey as gold standard, based
on a set of assumptions,44 with propensity score techni-
ques to address under-reporting in China’s DSP mortal-
ity data.40 The authors found the propensity score
approach to correct more accurately for under-reporting
and it is that adjusted data set that we have analysed in
this study. It should be acknowledged, however, that
death information for China’s ‘floating’ population (eg,
urban migrants without permanent residency) is incom-
plete and could not be analysed as a distinct group
within this study.
By focusing on mortality and a relatively short study
period of 7 years, including 3 years both prior and subse-
quent to the 2009 health reforms, other early benefits
could not be assessed. These may include better geo-
graphical access to healthcare and health promotion
activities that enhance community well-being, the results
of which are more likely to emerge much later. A limita-
tion of the analysis is that the DSP system, at 161 loca-
tions, did not contain information on the healthcare
environments provided in each area during the time
period. Our use of random coefficient multilevel models
circumvented this limitation to a degree by allowing
mortality trajectories for every DSP to vary over time
(rather than adhere to a fixed slope for the entire
country). This is an important methodological strength
since, as we have already reflected on, it is unlikely that
all areas of China witnessed the same level of change
postreform within the short time period of this study.
Further work is warranted in this regard to ascertain
how much change had occurred in terms of healthcare
provision at a local level.
In conclusion, mixed findings in this time-series ana-
lysis of health service amenable mortality and negative
outcomes indicate that it may be too early to identify
appreciable benefits of the expansion of health coverage
across China. Far from refuting the position that univer-
sal healthcare is an essential social good, our study
demonstrates the need for more in-depth epidemio-
logical investigation on the potential benefits for health
status, lifestyle and health service use related factors that
may yet determine clear reductions in amenable mortal-
ity across China.
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Year×Mean years of
education
0.98 (0.97 to 0.99) 0.99 (0.98 to 1.00)
Year2×Mean years of
education





0.176 (0.021) [1.49] 0.148 (0.017) [1.44] 0.068 (0.008) [1.28] 0.054 (0.007) [1.25]
Covariance (SE) −0.003 (0.003) −0.007 (0.003) −0.008 (0.002) −0.009 (0.002)
Slope variance (SE) 0.005 (0.001) 0.004 (0.001) 0.004 (0.001) 0.004 (0.001)
DSP, disease surveillance point; MRR, median rate ratio.
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